米索前列醇联合钙剂应用于预防与治疗产后出血

目的:研究口服米索前列醇防治产后出血的可行性,有效性和安全性。方法:在我院内选择正常月妊娠阴道分娩者100例,将其完全随机分为两组,每组研究50例,研究组在胎盘娩出后口服国产米索前列醇600μg;对照则在胎盘娩出后宫体注射缩宫素20iu,观察产后2h内的出血量及产后出血发生率。结果:产后2h内的出血量及产后出血发生率,研究组均较对照组要低,进行统计学分析,差异有显著地意义(p<0.05)。结论:口服米索前列醇防治产后出血是一种安全、有效的方法且效果优于缩宫素。如果联合钙剂应用于产后出血效果则更为突出。

Objective： To study the curative effect and the feasibility of the treatment of postpartum haemorrhage with misoprostol. Method： choice in my hospital on a normal vaginal delivery were 100 cases of pregnancy, will it completely randomly divided into two groups, each group studied 50 cases, the Study Group made in the placenta after the oral administration of misoprostol 600μg; control body in the placenta Temple injection of oxytocin 20iu, observed within 2h post-partum bleeding volume and the incidence of postpartum hemorrhage. Results.. within 2h postpartum bleeding volume and the incidence of postpartum hemorrhage study group was lower than those in the control group carried out statistiealanalysis, thediffereneewassignifieantlysignificant（p〈0.05）.Conclusions.. Preventionofpostparmmhemorrhageoforalmisoprostolisasafe and effective method and more effective than oxytocin. If the joint effects of calcium applied to post-partum haemorrhage was more prominent.